Skip to Main Content

Paper Details

A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas.
J Neurooncol
36
2015
AGs, DVT, GBMs, NF-kB, Patients, anaplastic gliomas, bortezomib, dyspnea, glioblastomas, glioma, headache, hyponatremia, hypophosphatemia, lymphopenia, malignant gliomas, patient, patients, peripheral neuropathy, tamoxifen, thromobocytopenia
Author NameAffiliation
Yazmin OdiaNeurological Institute of New York, Columbia University College of Physicians and Surgeons
Howard A FineNew York-Presbyterian Hospital/Weill Cornell Medical Center
  • 1 - 2

Datasets

Release 1.2